Lyell Immunopharma (LYEL) Leases (2020 - 2025)
Historic Leases for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $19.9 million.
- Lyell Immunopharma's Leases fell 4568.76% to $19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 million, marking a year-over-year decrease of 4568.76%. This contributed to the annual value of $24.7 million for FY2024, which is 3762.7% down from last year.
- Lyell Immunopharma's Leases amounted to $19.9 million in Q3 2025, which was down 4568.76% from $21.0 million recorded in Q2 2025.
- Over the past 5 years, Lyell Immunopharma's Leases peaked at $48.4 million during Q2 2021, and registered a low of $19.9 million during Q3 2025.
- In the last 5 years, Lyell Immunopharma's Leases had a median value of $41.1 million in 2023 and averaged $38.1 million.
- As far as peak fluctuations go, Lyell Immunopharma's Leases plummeted by 99.77% in 2021, and later crashed by 4568.76% in 2025.
- Quarter analysis of 5 years shows Lyell Immunopharma's Leases stood at $46.5 million in 2021, then decreased by 7.09% to $43.2 million in 2022, then decreased by 8.28% to $39.7 million in 2023, then plummeted by 37.63% to $24.7 million in 2024, then dropped by 19.51% to $19.9 million in 2025.
- Its last three reported values are $19.9 million in Q3 2025, $21.0 million for Q2 2025, and $23.6 million during Q1 2025.